Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.420
+0.040 (1.18%)
At close: Nov 19, 2025, 4:00 PM EST
3.420
0.00 (0.00%)
After-hours: Nov 19, 2025, 5:01 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $19.17 million as of November 19, 2025. Its market cap has increased by 64.44% in one year.
Market Cap
19.17M
Enterprise Value
16.85M
1-Year Change
64.44%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $19.17M, a decrease of -70.18%. That is a compound annual growth rate of -26.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 19.17M | 17.78% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 244.75B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |